Evidence map›Paper›PMID 42467138›Full record

ArticleInternational microbiology : the official journal of the Spanish Society for Microbiology2026

A novel Aureobasidium pullulans isolate for the biological control of Penicillium commune in potato decay and its optimization for enhanced antifungal activity using the Taguchi method.

Noushin Shafiee, Keivan Beheshti-Maal, Hamid Reza Akkafi, Hashem Nayeri

Abstract read
PubMed Publisher
In one paragraph

Article in International microbiology : the official journal of the Spanish Society for Microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Noushin ShafieeDepartment of Microbiology, Faculty of Biological Sciences, Fal. C, Islamic Azad University, Falavarjan, Isfahan, Iran.
Keivan Beheshti-MaalDepartment of Microbiology, Faculty of Biological Sciences, Fal. C, Islamic Azad University, Falavarjan, Isfahan, Iran. kbeheshtimaal@iau.ac.ir.
Hamid Reza AkkafiDepartment of Plant Science, Faculty of Biological Sciences, Fal. C, Islamic Azad University, Falavarjan, Isfahan, Iran.
Hashem NayeriDepartment of Biochemistry, Faculty of Biological Sciences, Fal. C, Islamic Azad University, Falavarjan, Isfahan, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Penicillium commune is a significant postharvest fungal pathogen responsible for blue mold rot in stored potatoes, resulting in substantial economic losses worldwide. In this study, we isolated and characterized a novel epiphytic strain of Aureobasidium pullulans SBAN-IAUF-1 from potato foliage and evaluated its antagonistic activity against Penicillium commune SBAN-IAUF-12. The new isolate exhibited strong inhibitory effects, reducing pathogen growth by 60% in vitro and 69.41% in vivo, outperforming values reported for most previously studied A. pullulans strains. Extracellular antifungal metabolites produced by Aureobasidium pullulans SBAN-IAUF-1 also showed substantial antifungal activity, indicating that extracellular antifungal metabolites play a key role in antagonism. To further enhance extracellular antifungal metabolites activity, we applied a Taguchi L9 orthogonal design, which identified optimal culture conditions and significantly increased the extracellular antifungal metabolites activity. The optimal conditions suggested by L9 analysis for maximizing extracellular antifungal metabolites production were 20 °C, 7 days of incubation, pH 5, and 1% (wv

Indexed as

Aureobasidium pullulansBiocontrol activityExtracellular antifungal metabolitesPenicillium communeTaguchi

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.